Delivery Order SPE2DB20D3101-SPE2DB25FRVA4
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,724.56 on September 3, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit, valued at $1,060.08 under a firm fixed price contract. This delivery order represents a non-set-aside award issued to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. The award serves military and federal healthcare supply needs through DLA's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,764.08 by the Medical Supply Chain division of the Defense Logistics Agency on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract involves the supply of Proctofoam-HC 1%-1% Foam in 10-gram units, a topical pharmaceutical product. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,034.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a non-set-aside competitive award with a completion date of September 11, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $1,257.60 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram quantities. This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages AmerisourceBergen Drug Corp's existing relationship with...
- The Defense Logistics Agency awarded a $1,832.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units. This non-set-aside delivery order, which must be completed by September 9, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving military...
- The Defense Logistics Agency awarded a $1,048.00 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a non-set-aside contract with an ultimate completion date of September 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- The Defense Logistics Agency awarded a $2,515.44 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam (10 grams) with an ultimate completion date of September 12, 2025. This is a firm fixed price delivery order with no set-aside designation, issued on September 11, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Proctofoam-HC 1%-1% foam in a 10-gram unit, with a ceiling value of $1,048.10. This competitively awarded contract uses firm fixed pricing and is classified as a non-set-aside procurement. The delivery order is expected to be completed by August 18, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,022.16 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam (10gm) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price contract, which carries no set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's Conshohocken,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRVA4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,515.04 to AmerisourceBergen Drug Corp on September 10, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, holds a significant $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX) running through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including critical medications, vaccines, and specialized medical commodities. The company's competitive federal procurement track record and extensive portfolio of medical product deliveries demonstrate its capability to meet DLA's medical supply chain requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 9/10/25 |